Shire image

Shire plots new ADHD drug approval

April 7, 2015
Sales and Marketing ADHD, FDA, SHP465, Shire, Vyvanse, clinical trials, paediatrics

Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …

Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

Mosquito image

Merck Serono signs antimalarial development deal

April 2, 2015
Research and Development, Sales and Marketing DDD107498, Medicines for Malaria Venture, Merck Serono, antimalarial, malaria

Merck Serono and Medicines for Malaria Venture (MMV) have signed an agreement which will see them advance the development of …

Rilutek (riluzole) image

Multiple sclerosis studies underway using existing drugs

April 2, 2015
Research and Development, Sales and Marketing MS, Midamor, Prozac, Rilutek, Sanofi, amiloride, covis, fluoxetine, multiple sclerosis, riluzole

Three existing drugs that fight heart disease, depression and motor neurone disease could be used to treat multiple sclerosis (MS) …

Thomas Webb image

Working Life: GlaxoSmithKline’s Thomas Webb

April 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Hong Kong, Working Life, macau, oncology, thomas webb

Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …

Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

jonathandancer_1

PM Society appoints two new members

April 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing colin williams, jonathan dancer, pm society

Not-for-profit healthcare marketing organisation PM Society has made two new appointments to its executive committee.  Jonathan Dancer (pictured) the managing …

Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

Merck image

Merck lines up early-stage Keytruda combo trial

April 1, 2015
Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax

Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …

charles_mackay_pfizer

Pfizer appoints inflammation and immunology head

April 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Reay Mackay, Pfizer

Professor Charles Reay Mackay is joining US pharma giant Pfizer as the chief scientific officer of its inflammation and immunology …

Teva image

Teva bolsters neurology unit through Auspex deal

March 31, 2015
Sales and Marketing CNS, SD-809, Teva, Tourette syndrome, auspex, deutetrabenazine, neurology

Teva is significantly enhancing its neurology business by acquiring US biopharma firm Auspex in a deal worth $3.5 billion. Teva …

Novartis image

Novartis drug to treat iron overload gets US nod

March 31, 2015
Sales and Marketing FDA, Novartis, blood, deferasirox, exjade, iron, jadenu

Novartis’ iron overload drug Jadenu has been given the green light by US regulators to treat patients with a serious …

Pfizer image

Pfizer is pharma’s biggest advertiser

March 31, 2015
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, advertising, adverts, dtc, lilly

US giant Pfizer spends far more on direct-to-consumer advertising than any other pharma firm according to new data from Kantar …

Merck Serono image

Merck Serono in $826m immuno-oncology deal

March 31, 2015
Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …

Genentech image

Roche subsidiary Genentech expands in manufacturing

March 31, 2015
Manufacturing and Production, Sales and Marketing Genentech, Roche, hillsboro, manufacturing, oregon

Californian drugmaker Genentech is planning a $125 million expansion at its Hillsboro manufacturing centre in Oregon. The Roche subsidiary plant …

john_bell

Immunocore appoints key scientist to board

March 31, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell

UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …

Professor John Weinman image

Addressing the adherence gap

March 30, 2015
Research and Development, Sales and Marketing AstraZeneca, Kings College London, Professor John Weinman, adherence

Poor medication use in patients with long-term health conditions is widely recognised as a global problem that urgently needs to …

Novartis in major oncology drive

March 30, 2015
Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia

Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …

Google image

J&J and Google partner to build surgical robots

March 30, 2015
Medical Communications, Sales and Marketing Biogen, Ethicon, J&J, JJ, Johnson and Johnson, MS, google, robots

The medical device subsidiary of Johnson & Johnson Ethicon is to collaborate with Google to build surgical robots and perform …

GSK image

GSK and UK government agree meningitis B vaccine deal

March 30, 2015
Sales and Marketing AstraZeneca, Bexsero, GSK, Novartis, meningitis v, vaccines

The UK government has agreed a deal with GlaxoSmithKline to provide its meningitis B vaccine Bexsero on the NHS, after …

The Gateway to Local Adoption Series

Latest content